Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Champions Oncolog (NQ: CSBR ) 5.045 +0.125 (+2.54%) Streaming Delayed Price Updated: 4:00 PM EDT, Jul 19, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 21,949 Open 5.160 Bid (Size) 5.000 (3) Ask (Size) 5.780 (1) Prev. Close 4.920 Today's Range 4.927 - 5.442 52wk Range 4.500 - 7.130 Shares Outstanding 13,415,066 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News CSBR Stock Earnings: Champions Oncology Beats EPS, Beats Revenue for Q4 2024 July 18, 2024 CSBR stock results show that Champions Oncology beat analyst estimates for earnings per share and beat on revenue for the fourth quarter of 2024. Via InvestorPlace Champions Oncology Reports Quarterly Revenue of $14.0 Million July 18, 2024 Via ACCESSWIRE Performance YTD -12.87% -12.87% 1 Month +4.45% +4.45% 3 Month -0.49% -0.49% 6 Month -20.92% -20.92% 1 Year -27.62% -27.62% More News Read More Champions Oncology to Announce Fourth Quarter and Year-End Financial Results on Thursday, July 18, 2024 July 11, 2024 Via ACCESSWIRE 12 Health Care Stocks Moving In Monday's Intraday Session June 10, 2024 Via Benzinga 12 Health Care Stocks Moving In Wednesday's Intraday Session June 05, 2024 Via Benzinga Champions Oncology: Q3 Earnings Insights March 12, 2024 Via Benzinga Earnings Outlook For Champions Oncology March 11, 2024 Via Benzinga Recap: Champions Oncology Q2 Earnings December 12, 2023 Via Benzinga Champions Oncology and Medicines Discovery Catapult Forge Partnership to Accelerate Radiopharmaceutical Therapeutics Development June 04, 2024 Via ACCESSWIRE Champions Oncology Reports Quarterly Revenue of $12.0 Million March 12, 2024 Via ACCESSWIRE Earnings Scheduled For March 12, 2024 March 12, 2024 Via Benzinga Champions Oncology's US Laboratory has Acquired Distinguished CAP Accreditation March 07, 2024 Via ACCESSWIRE Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024 March 06, 2024 Via ACCESSWIRE Insiders Buying Solid Biosciences And 2 Other Stocks January 16, 2024 Via Benzinga Insiders Buying Tilly's And 2 Other Stocks January 10, 2024 Via Benzinga Why Is RiskOn International (ROI) Stock Up 28% Today? December 13, 2023 Via InvestorPlace CSBR Stock Earnings: Champions Oncology Beats EPS, Misses Revenue for Q2 2024 December 12, 2023 Via InvestorPlace Champions Oncology Reports Quarterly Revenue of $11.6 Million December 12, 2023 Via ACCESSWIRE Earnings Scheduled For December 12, 2023 December 12, 2023 Via Benzinga Johnson Controls, Oracle And 3 Stocks To Watch Heading Into Tuesday December 12, 2023 Via Benzinga Investor Optimism Improves Further Ahead Of Inflation Data; Dow Gains For Third Straight Day December 12, 2023 Via Benzinga Topics Economy Stocks Exposures Interest Rates US Equities Champions Oncology to Announce Second Quarter Financial Results on Tuesday, December 12, 2023 December 04, 2023 Via ACCESSWIRE Champions Oncology's European Research Operations Site Receives ISO-9001:2015 Accreditation and ATS Certification November 02, 2023 Via ACCESSWIRE Champions Oncology Announces the Addition of Brady Davis as President October 17, 2023 Via ACCESSWIRE Champions Oncology Reports Quarterly Revenue of $12.6 Million September 13, 2023 Via ACCESSWIRE Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
